Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 33,776	$ 24,395
General and administrative	7,283	5,636
Total operating expenses	41,059	30,031
Loss from operations	(41,059)	(30,031)
Interest and other income, net	1,998	980
Net loss	(39,061)	(29,051)
Other comprehensive loss:
Unrealized gain (loss) on investments, net		1
Comprehensive loss	$ (39,061)	$ (29,050)
Net loss per common share, basic	$ (1.09)	$ (0.98)
Net loss per common share, diluted	$ (1.09)	$ (0.98)
Weighted-average number of common shares used to compute basic net loss per common share	35,890,370	29,586,468
Weighted-average number of common shares used to compute diluted net loss per common share	35,890,370	29,586,468